Product NDC: | 63323-145 |
Proprietary Name: | Floxuridine |
Non Proprietary Name: | FLOXURIDINE |
Active Ingredient(s): | 500 mg/5mL & nbsp; FLOXURIDINE |
Administration Route(s): | INTRA-ARTERIAL |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-145 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075837 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010315 |
Package NDC: | 63323-145-07 |
Package Description: | 1 VIAL in 1 CARTON (63323-145-07) > 5 mL in 1 VIAL |
NDC Code | 63323-145-07 |
Proprietary Name | Floxuridine |
Package Description | 1 VIAL in 1 CARTON (63323-145-07) > 5 mL in 1 VIAL |
Product NDC | 63323-145 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FLOXURIDINE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRA-ARTERIAL |
Start Marketing Date | 20010315 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | FLOXURIDINE |
Strength Number | 500 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Antimetabolite [EPC],Deoxyuridine [Chemical/Ingredient] |